Bertuglia, G.; Cani, L.; Larocca, A.; Gay, F.; D’Agostino, M.
Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma? Int. J. Mol. Sci. 2022, 23, 15879.
https://doi.org/10.3390/ijms232415879
AMA Style
Bertuglia G, Cani L, Larocca A, Gay F, D’Agostino M.
Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma? International Journal of Molecular Sciences. 2022; 23(24):15879.
https://doi.org/10.3390/ijms232415879
Chicago/Turabian Style
Bertuglia, Giuseppe, Lorenzo Cani, Alessandra Larocca, Francesca Gay, and Mattia D’Agostino.
2022. "Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?" International Journal of Molecular Sciences 23, no. 24: 15879.
https://doi.org/10.3390/ijms232415879
APA Style
Bertuglia, G., Cani, L., Larocca, A., Gay, F., & D’Agostino, M.
(2022). Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma? International Journal of Molecular Sciences, 23(24), 15879.
https://doi.org/10.3390/ijms232415879